DAI Jingjing, HOU Lili. Correlation of neoadjuvant-related complications and constitutive features of traditional Chinese medicine in patients with osteosarcoma[J]. Journal of Clinical Medicine in Practice, 2021, 25(22): 38-41. DOI: 10.7619/jcmp.20212886
Citation: DAI Jingjing, HOU Lili. Correlation of neoadjuvant-related complications and constitutive features of traditional Chinese medicine in patients with osteosarcoma[J]. Journal of Clinical Medicine in Practice, 2021, 25(22): 38-41. DOI: 10.7619/jcmp.20212886

Correlation of neoadjuvant-related complications and constitutive features of traditional Chinese medicine in patients with osteosarcoma

More Information
  • Received Date: July 18, 2021
  • Available Online: November 12, 2021
  • Published Date: November 27, 2021
  •   Objective  To investigate the correlation of neoadjuvant complications and constitutive features of traditional Chinese medicine(TCM) in patients with osteosarcoma.
      Methods  A total of 74 patients who underwent neoadjuvant therapy for osteosarcoma were recruited. All patients received neoadjuvant therapy before surgery. The occurrence of complications was observed, and the correlation between complications and constitutive features of TCM was analyzed.
      Results  Yang deficiency and qi stagnation constitution were the main TCM constitution types of osteosarcoma patients, followed by phlegm dampness, qi deficiency, dampness heat, and blood stasis as well as yin deficiency constitutions. Gastrointestinal reaction was the most common complication, which related to qi stagnation, yang deficiency, blood stasis, phlegm-dampness and damp-heat constitutions (P < 0.05); TCM constitutions including dampness heat, qi deficiency and qi stagnation types related to liver function damage (P < 0.05); the mucosa damage, nephrotoxicity and cardiotoxicity were relatively rare, among which nephrotoxicity related to qi deficiency, yang deficiency and blood stasis constitutions (P < 0.05); there was no relation between TCM constitution and cardiotoxicity as well as mucosal damage (P>0.05).
      Conclusion  The occurrence of complications during neoadjuvant therapy is closely related to TCM constitution. Therefore, providing intervention from the perspective of TCM constitution for osteosarcoma patients could reduce the incidence of complications.
  • [1]
    李战鹏. 骨肉瘤患者在不同新辅助化疗方案实施前后多药耐药相关蛋白在mRNA及蛋白水平中的表达变化[J]. 河北医药, 2019, 41(3): 432-434. https://www.cnki.com.cn/Article/CJFDTOTAL-HBYZ201903027.htm
    [2]
    司富春, 丁帅伟. 骨肉瘤中医证型与方药分析研究[J]. 世界中西医结合杂志, 2015, 15(7): 903-907. https://www.cnki.com.cn/Article/CJFDTOTAL-SJZX201507005.htm
    [3]
    流小舟, 于沂阳, 施鑫, 等. 骨肉瘤复发患者的转归及影响长期生存的因素分析: 一项基于多中心骨肉瘤复发患者的长期随访研究[J]. 中华骨科杂志, 2018(18): 1089-1096. doi: 10.3760/cma.j.issn.0253-2352.2018.18.001
    [4]
    唐晶晶, 汪硕闻, 朱蓓琳, 等. 大剂量甲氨蝶呤治疗骨肉瘤患者时甲氨蝶呤及其代谢产物血药浓度与不良反应相关性研究[J]. 中南药学, 2019, 17(3): 450-454. https://www.cnki.com.cn/Article/CJFDTOTAL-ZNYX201903025.htm
    [5]
    QIANG WEI. A study on the relationship between bladder cancer recurrence and side effects of intravesical pirarubicin chemotherapy and the evaluation of quality of life[J]. International Journal of Urology, 2014, 21(2): A222-A222. doi: 10.1111/iju.12219
    [6]
    许卫东, 陈刚, 谷凌云. 中医辨证治疗直肠癌放化疗毒副反应70例分析[J]. 吉林中医药, 2015, 35(8): 803-805. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYJL201508015.htm
    [7]
    陈洪华, 罗玉红, 刘佩珍, 等. 骨科青少年骨肉瘤患者新辅助化疗的护理[J]. 实用医学杂志, 2010, 26(13): 2456-2458. doi: 10.3969/j.issn.1006-5725.2010.13.078
    [8]
    INOUE Y, FUJII K, ISHII M, et al. The relationship between postoperative chemotherapy and remnant liver regeneration and outcomes after hepatectomy for colorectal liver metastasis[J]. J Gastrointest Surg, 2019, 23(10): 1973-1983. doi: 10.1007/s11605-018-3952-1
    [9]
    刘琦, 李晓阳, 肖涛. 骨肉瘤优化新辅助化疗方案临床疗效观察[J]. 中国医师杂志, 2014, 16(5): 634-637. doi: 10.3760/cma.j.issn.1008-1372.2014.05.016
    [10]
    浦飞飞, 陈凤霞, 冯晶, 等. 湖北地区骨肉瘤患者中医证型与临床病理学的相关性分析[J]. 中国中医骨伤科杂志, 2019, 27(9): 42-45. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZG201909010.htm
    [11]
    PENG X U, ONCOLOGY D O. Study on the relationship between Chemotherapy toxicity of Capecitabine of colon cancer and TCM constitution classification[J]. Heb Journal of Traditional Chinese Medicine, 2018, 28(17): 327-329. http://en.cnki.com.cn/Article_en/CJFDTOTAL-HBZY201801010.htm
    [12]
    CHLOE F, CARLENE W, HUTCHINSON A D, et al. The relationship between anticipated response and subsequent experience of cancer treatment-related side effects: A meta-analysis comparing effects before and after treatment exposure[J]. Cancer Treatment Reviews, 2018, 68(6): 86-93. http://www.sciencedirect.com/science/article/pii/S0305737218301038
  • Related Articles

    [1]ZHANG Manqi, ZHA Hailing, LIU Xinpei, WANG Jue, CHEN Rui, LI Cuiying. Accuracy of ultrasonic evaluation of neoadjuvant chemotherapy for breast cancer and analysis of influencing factors[J]. Journal of Clinical Medicine in Practice, 2022, 26(13): 45-49, 54. DOI: 10.7619/jcmp.20220387
    [2]CHI Wencheng, GENG Xue, JIANG Jiakang, JIANG Qinghui, ZHOU Yunbo, ZOU Xiangni. Research progress on integrated therapy of traditional Chinese and western medicine in treatment of adverse reactions after tumor chemotherapy[J]. Journal of Clinical Medicine in Practice, 2022, 26(8): 126-130. DOI: 10.7619/jcmp.20214971
    [3]HU Sainan, ZHANG Lili, YU Qiao, HU Yiqing, YUAN Yuan, GAO Jin. Clinical effect of dose-dense neoadjuvant chemotherapy in the treatment of breast cancer[J]. Journal of Clinical Medicine in Practice, 2015, (19): 39-43. DOI: 10.7619/jcmp.201519012
    [4]LAI Xiaodong, GUO Yanchun, WANG Xunguo. Effect of intensity modulated radiation therapy combined with neoadjuvant endocrine therapy on treatment of localised prostate cancer and the influencing factors[J]. Journal of Clinical Medicine in Practice, 2015, (13): 33-36. DOI: 10.7619/jcmp.201513010
    [5]LIN Weijia, TANG Liming, ZHENG Lin. Effects of neoadjuvant chemotherapy on different molecular subtypes of breast cancer[J]. Journal of Clinical Medicine in Practice, 2014, (21): 75-77,84. DOI: 10.7619/jcmp.201421021
    [6]XIE Huijun, YUAN Mingming, WANG Weiwei, CAI Dewei. Expression of Survivin, VEGF and Ki-67 before and after neoadjuvant chemotherapy and its clinical significance in patients with cervical cancer[J]. Journal of Clinical Medicine in Practice, 2014, (19): 81-83,87. DOI: 10.7619/jcmp.201419024
    [7]LI Tianren, CHANG Hua, GUO Kejun. Evaluation of the clinical effects of interferon combined with neoadjuvant chemotherapy on ovarian cancer complicated with ascites[J]. Journal of Clinical Medicine in Practice, 2014, (16): 171-173. DOI: 10.7619/jcmp.201416058
    [8]ZHANG Chunlin, ZHAO Lin. Clinical application of neoadjuvant therapy in advanced gastric cancer and its effect on prognosis[J]. Journal of Clinical Medicine in Practice, 2013, (21): 46-49. DOI: 10.7619/jcmp.201321013
    [9]ZHANG Xiang, YU Meixian, ZHOU Yajuan, ZHU Yingqin, ZHOU Lijun. Perioperative nursing for patients with advanced gastric cancer after neoadjuvant chemotherapy[J]. Journal of Clinical Medicine in Practice, 2013, (8): 7-9. DOI: 10.7619/jcmp.201308003
    [10]NIE Jian-yun, ZOU Tian-ning, CHEN De-dian, CHEN Wen-lin. EFFECT OF NEO-ADJUVANT CHEMOTHERAPY ON PATHOLOGICAL STAGE AND DESIGNING OF THERAPY PLAN FOR BREAST CANCER[J]. Journal of Clinical Medicine in Practice, 2005, (7): 41-42. DOI: 10.3969/j.issn.1672-2353.2005.07.013
  • Cited by

    Periodical cited type(6)

    1. 韩秀燕,许华,张沁丽. 血清尿酸水平与脑血管病因果关系的双向两样本孟德尔随机化研究. 实用临床医药杂志. 2025(01): 66-72 . 本站查看
    2. 罗丽,刘锋伟,马丹丹,张玮. 靳三针联合感觉统合训练治疗儿童语言障碍对语言功能及适应行为的影响. 实用中医药杂志. 2024(04): 749-751 .
    3. 刘洁洁,唐纯志. 靳三针疗法治疗痴呆Meta分析. 中国中医药图书情报杂志. 2024(04): 171-177 .
    4. 唐青青,李铁,李霞,杨宁,张世苹,张凯强,萨仁. 萨仁“南海调神”针法经验浅析. 中国针灸. 2024(10): 1177-1180 .
    5. 刘红喜,路梦颖,梁晓,魏竞竞,刘悦,陈云梦,迟显苏,付国静,张允岭. 基于髓海理论运用填精益髓法辨治中医脑病. 中医杂志. 2023(18): 1877-1884 .
    6. 杜明明,刘仕杰,宋金萍,谷慧敏. 补髓通窍益脑汤联合靳三针对血管性痴呆患者的影响. 光明中医. 2023(18): 3564-3566 .

    Other cited types(2)

Catalog

    Article views (267) PDF downloads (11) Cited by(8)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return